|
| related topics |
| {product, liability, claim} |
| {operation, international, foreign} |
| {customer, product, revenue} |
| {condition, economic, financial} |
| {regulation, government, change} |
| {product, market, service} |
| {financial, litigation, operation} |
| {property, intellectual, protect} |
| {personnel, key, retain} |
|
|
A Weak Economy Could Result in Reduced Demand for Our Products and Services
Disruption in Financial and Currency Markets Could Have a Negative Effect on Our Business
Strengthening of the Rate of Exchange for the U.S. Dollar Has a Negative Effect on Our Business
Our Dependence on a Limited Number of Suppliers Could Limit Our Ability to Sell Certain Products or Reduce Our Profitability
Our Biologic Products Are Complex and Difficult to Manufacture, Which Could Negatively Affect Our Ability to Supply the Market
Various Government Regulations Could Limit or Delay Our Ability to Market and Sell Our Products
Our Success Is Heavily Dependent Upon Our Proprietary Technologies
Distributor Purchasing Patterns Could Negatively Affect Our Operating Results
Increased Competition and Technological Advances by Our Competitors Could Negatively Affect Our Operating Results
Changes in Testing Patterns Could Negatively Affect Our Operating Results
Consolidation of Veterinary Hospitals Could Negatively Affect Our Business
Our Inexperience in the Human Point-of-Care Market Could Inhibit Our Success in this Market
Risks Associated with Doing Business Internationally Could Negatively Affect Our Operating Results
The Loss of Our President, Chief Executive Officer and Chairman Could Adversely Affect Our Business
We Could Be Subject to Class Action Litigation Due to Stock Price Volatility, which, if it Occurs, Could Result in Substantial Costs or Large Judgments Against Us
Full 10-K form ▸
|
|
| related documents |
| 874716--2/19/2010--IDEXX_LABORATORIES_INC_/DE |
| 313143--5/27/2008--HAEMONETICS_CORP |
| 1270597--3/23/2007--MERISANT_CO |
| 26172--2/26/2008--CUMMINS_INC |
| 780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 26172--2/27/2007--CUMMINS_INC |
| 26172--2/28/2006--CUMMINS_INC |
| 313143--5/25/2007--HAEMONETICS_CORP |
| 10456--2/19/2009--BAXTER_INTERNATIONAL_INC |
| 854860--12/15/2009--WILLIAMS_CONTROLS_INC |
| 736822--7/27/2007--IMMUCOR_INC |
| 102037--5/27/2010--UNIVERSAL_CORP_/VA/ |
| 10795--11/24/2010--BECTON_DICKINSON_&_CO |
| 1270597--3/31/2006--MERISANT_CO |
| 1110783--10/26/2007--MONSANTO_CO_/NEW/ |
| 70793--11/30/2009--NBTY_INC |
| 10795--11/26/2008--BECTON_DICKINSON_&_CO |
| 929987--2/22/2006--GUIDANT_CORP |
| 31791--3/1/2010--PERKINELMER_INC |
| 795403--3/1/2010--WATTS_WATER_TECHNOLOGIES_INC |
| 12355--2/15/2006--BLACK_&_DECKER_CORP |
| 885725--3/1/2006--BOSTON_SCIENTIFIC_CORP |
| 911160--6/2/2010--RF_MICRO_DEVICES_INC |
| 880432--9/28/2009--MISONIX_INC |
| 811669--2/23/2007--UST_INC |
| 10795--11/30/2006--BECTON_DICKINSON_&_CO |
| 854860--12/11/2008--WILLIAMS_CONTROLS_INC |
| 10795--11/23/2007--BECTON_DICKINSON_&_CO |
| 10795--11/25/2009--BECTON_DICKINSON_&_CO |
| 65270--7/1/2010--METHODE_ELECTRONICS_INC |
|